Qingdao Vland Biotech INC. engages in the research and development of enzymes, probiotics, and animal vaccines and health products. It offers animal feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated poultry, and swine vaccines, as well as antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, paper making, household cleaning and detergents, food, biofuel, environmental protection, and other industries. The company was incorporated in 2005 and is headquartered in Qingdao, China. Qingdao Vland Biotech INC. operates as a subsidiary of Qingdao Kangdien Industrial Co., Ltd.

6037

SHH:603739

Qingdao Vland Biotech INC.

Last Close

11.62

26/07 07:00

Market Cap

3.20B

Beta: −0.15

Volume Today

3.64M

Avg: 1.15M

PE Ratio

26.77

PFCF: −17.91

Dividend Yield

1.10%

Payout:49.05%

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics